Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartolozzi, C.
Right arrow Articles by DiCoscio, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartolozzi, C.
Right arrow Articles by DiCoscio, G.

Radiology, Vol 191, 123-128, Copyright © 1994 by Radiological Society of North America


ARTICLES

Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection

C Bartolozzi, R Lencioni, D Caramella, F Falaschi, R Cioni and G DiCoscio
Department of Radiology, University of Pisa, Italy.

PURPOSE: To investigate the reliability of computed tomography (CT) and magnetic resonance (MR) imaging in the evaluation of the response of hepatocellular carcinoma (HCC) to transcatheter arterial embolization (TAE) followed by percutaneous ethanol injection (PEI). MATERIAL AND METHODS: Between January 1991 and November 1992, 20 patients (15 men and five women, aged 53-73 years [mean, 64.6 years]) with 31 HCC lesions underwent CT and MR imaging before and after treatment with combined TAE and PEI. RESULTS: Twenty-seven tumors, which were hypointense on post-treatment T2-weighted images and on gadolinium- enhanced T1-weighted images, were seen to be necrotic at biopsy. In four cases of incomplete necrosis, viable tumor was hyperintense on T2- weighted images and was enhanced after administration of contrast material. CT provided a larger spectrum of imaging features as a result of the presence of both hyperattenuating areas (caused by retention of iodized oil) and hypoattenuating areas (due to ethanol-induced necrosis). CONCLUSION: CT and MR imaging findings proved useful in the evaluation of the response of HCC to combined TAE and PEI.


This article has been cited by other articles:


Home page
J Ultrasound MedHome page
H. J. Kim, T. K. Kim, P. N. Kim, A. Y. Kim, E. Y. Ko, K. W. Kim, K.-B. Sung, H. K. Ha, H. C. Kim, and M.-G. Lee
Assessment of the Therapeutic Response of Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization: Comparison of Contrast-Enhanced Sonography and 3-Phase Computed Tomography
J. Ultrasound Med., April 1, 2006; 25(4): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. K. Kim, K.-H. Han, J. T. Lee, Y. H. Paik, S. H. Ahn, J. D. Lee, K. S. Lee, C. Y. Chon, and Y. M. Moon
Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex (Milican) for the Treatment of Small Hepatocellular Carcinoma
Clin. Cancer Res., January 15, 2006; 12(2): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
F. Wu, Z.-B. Wang, W.-Z. Chen, J.-Z. Zou, J. Bai, H. Zhu, K.-Q. Li, C.-B. Jin, F.-L. Xie, and H.-B. Su
Advanced Hepatocellular Carcinoma: Treatment with High-Intensity Focused Ultrasound Ablation Combined with Transcatheter Arterial Embolization
Radiology, May 1, 2005; 235(2): 659 - 667.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. V. Pandharipande, G. A. Krinsky, H. Rusinek, and V. S. Lee
Perfusion Imaging of the Liver: Current Challenges and Future Goals
Radiology, March 1, 2005; 234(3): 661 - 673.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. W. Wilson, R. K. Kerlan Jr, N. A. Fidelman, A. P. Venook, J. M. LaBerge, J. Koda, and R. L. Gordon
Hepatocellular Carcinoma: Regional Therapy with a Magnetic Targeted Carrier Bound to Doxorubicin in a Dual MR Imaging/ Conventional Angiography Suite--Initial Experience with Four Patients
Radiology, January 1, 2004; 230(1): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. H. Youk, J. M. Lee, and C. S. Kim
Therapeutic Response Evaluation of Malignant Hepatic Masses Treated by Interventional Procedures With Contrast-Enhanced Agent Detection Imaging
J. Ultrasound Med., September 1, 2003; 22(9): 911 - 920.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Y. L. Wen, M. Kudo, R. Q. Zheng, Y. Minami, H. Chung, Y. Suetomi, H. Onda, M. Kitano, T. Kawasaki, and K. Maekawa
Radiofrequency Ablation of Hepatocellular Carcinoma: Therapeutic Response Using Contrast-Enhanced Coded Phase-Inversion Harmonic Sonography
Am. J. Roentgenol., July 1, 2003; 181(1): 57 - 63.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. Morimoto, K. Shirato, K. Sugimori, A. Kokawa, N. Tomita, T. Saito, T. Imada, N. Tanaka, A. Nozawa, K. Numata, et al.
Contrast-Enhanced Harmonic Gray-Scale Sonographic-Histologic Correlation of the Therapeutic Effects of Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma
Am. J. Roentgenol., July 1, 2003; 181(1): 65 - 69.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. K. Kim, H. K. Lim, Y. H. Kim, W. J. Lee, S. J. Lee, S. H. Kim, J. H. Lim, and S. A. Kim
Hepatocellular Carcinoma Treated with Radio-frequency Ablation: Spectrum of Imaging Findings
RadioGraphics, January 1, 2003; 23(1): 107 - 121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Numata, K. Tanaka, T. Kiba, S. Saito, T. Isozaki, K. Hara, M. Morimoto, H. Sekihara, H. Yonezawa, and T. Kubota
Using Contrast-Enhanced Sonography to Assess the Effectiveness of Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Am. J. Roentgenol., May 1, 2001; 176(5): 1199 - 1205.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. Ding, M. Kudo, H. Onda, Y. Suetomi, Y. Minami, and K. Maekawa
Contrast-Enhanced Subtraction Harmonic Sonography for Evaluating Treatment Response in Patients with Hepatocellular Carcinoma
Am. J. Roentgenol., March 1, 2001; 176(3): 661 - 666.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Takayasu, S. Arii, N. Matsuo, M. Yoshikawa, M. Ryu, K. Takasaki, M. Sato, N. Yamanaka, Y. Shimamura, and M. Ohto
Comparison of CT Findings with Resected Specimens After Chemoembolization with Iodized Oil for Hepatocellular Carcinoma
Am. J. Roentgenol., September 1, 2000; 175(3): 699 - 704.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Koito, T. Namieno, T. Ichimura, N. Hirokawa, T. Syonai, M. Hareyama, T. Katsuramaki, K. Hirata, and M. Nishi
Power Doppler Sonography: Evaluation of Hepatocellular Carcinoma After Treatment with Transarterial Embolization or Percutaneous Ethanol Injection Therapy
Am. J. Roentgenol., February 1, 2000; 174(2): 337 - 341.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. K. Lim, D. Choi, W. J. Lee, S. H. Kim, S. J. Lee, H.-J. Jang, J.-H. Lee, J. H. Lim, and I. W. Choo
Hepatocellular Carcinoma Treated with Percutaneous Radio-frequency Ablation: Evaluation with Follow-up Multiphase Helical CT
Radiology, November 1, 2001; 221(2): 447 - 454.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. Ding, M. Kudo, H. Onda, Y. Suetomi, Y. Minami, H. Chung, T. Kawasaki, and K. Maekawa
Evaluation of Posttreatment Response of Hepatocellular Carcinoma with Contrast-enhanced Coded Phase-Inversion Harmonic US: Comparison with Dynamic CT
Radiology, December 1, 2001; 221(3): 721 - 730.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1994 by the Radiological Society of North America.